Jeff Schorey

Jeff Schorey's projects emphasize collaborative solutions for tackling the complex challenges posed by mycobacterial diseases. As the George B. Craig Jr. Professor at the University of Notre Dame, he leads pioneering research focused on the intricate interactions between mycobacteria and macrophages. His research team delves deep into the molecular dynamics that occur during infection, shedding light on the mechanisms that drive disease progression and immune response. A significant aspect of Schorey's work involves exploring the role of exosomes in disease transmission and the host's immune response. By understanding how these small vesicles contribute to the spread of infection and the body's defense mechanisms, his research aims to uncover novel therapeutic targets. This knowledge is crucial for developing innovative strategies to combat multi-drug-resistant strains of mycobacteria, a growing concern in the field of infectious diseases. Schorey's team is also at the forefront of evaluating new antibiotics, striving to find effective treatments against resistant strains. Their efforts are directed towards advancing the understanding of Mycobacterium-host interactions, which is essential for the development of improved diagnostic tools, vaccines, and antibiotics. Through these endeavors, Schorey aims to contribute significantly to the eradication of tuberculosis and other mycobacterial diseases, ultimately improving global health outcomes. In addition to his research, Schorey is committed to fostering a collaborative research environment, encouraging interdisciplinary approaches to address the pressing issues in infectious diseases. His work not only enhances scientific knowledge but also has the potential to transform public health strategies, offering hope for a future free from the burden of mycobacterial infections.